1. Introduction {#sec1}
===============

In Korea, the major route of HIV transmission is sexual contact (99%) and the ratio of men to women for HIV positivity is 11:1. The proportion of men who have sex with men (MSM) was approximately 40% of those infected [@bib1]. MSM are known to have more anorectal diseases compared with the general population [@bib2], and anal sex enhances HIV infection risk [@bib3].

Patients with HIV are chronically immunosuppressed, which may increase their risk for development of malignancies [@bib4; @bib5]. In many studies, HIV infection led to significantly increased rates of several cancers, including Hodgkin's disease, multiple myeloma, brain cancer, and seminoma [@bib6]. Anal cancer and its precursor anal intraepithelial neoplasia have a high prevalence in the HIV-positive population [@bib7]. The relative risk for developing anal cancer among HIV-positive MSM is 37 times higher than for the general population [@bib8].

Neoplastic lesions of colorectum detected by endoscopy (colonoscopy or sigmoidoscopy) were significantly more common in HIV-infected patients than in control subjects without HIV [@bib9]. Colorectal cancer is the third most common cancer (13%) in Korea, with \>7100 deaths resulting from the disease in 2009 [@bib10].

With recent increases in the number of specialized colorectal clinics and hospitals, persons who develop anorectal diseases due to anal intercourse or HIV infections tend to be treated in these centers. HIV-infected persons have more anorectal diseases, and the most frequent reason to undergo surgical operation is anorectal diseases [@bib11; @bib12; @bib13]. Therefore, this study aimed to identify HIV seroprevalence among patients in anorectal clinics/hospitals in Korea.

2. Methods {#sec2}
==========

2.1. Data collection {#sec2.1}
--------------------

The survey was conducted in colorectal hospitals in Korea from November to December 2008 and was co-sponsored by the Korea Centers for Disease Control (KCDC) and the Korean Society of Coloproctology (KSC). The Division of AIDS of KCDC designed a questionnaire to identify the status of HIV testing in colorectal hospitals. KSC distributed the questionnaire to 774 colorectal hospitals in Korea. KCDC gathered the data by the website (<http://hivqa.nih.go.kr/risk>) or by fax. The questionnaire comprised six topics about HIV testing, such as whether the colorectal hospital tested for HIV in their own hospital, the methods of HIV test, the reason for recommendation of HIV test to patients, the necessity for HIV test under endoscopy, and the annual number of HIV tests (2002--07).

2.2. HIV testing system {#sec2.2}
-----------------------

In Korea, HIV reactive samples from primary screening tests in hospital laboratories or clinical laboratories are referred to 17 local sites of the Institutions of Health and the Environment (IHE) for confirmatory tests. Unconfirmed reactive samples are referred to the Division of AIDS at KCDC, where final decision on HIV infection status for each sample is made. The results of positivity from IHE or from Division of AIDS are reported to the Division of HIV and TB control at KCDC, which manages the national HIV/AIDS database [@bib14].

2.3. Statistical methods {#sec2.3}
------------------------

HIV seroprevalence is defined as the number of HIV-infected individuals divided by the total number of HIV-tested individuals in a single year during the study period. The number of HIV-tested individuals was calculated by the repeated value per person-year from previous study on hospital-based HIV seroprevalence in Korea. The repeated value of HIV test per person-year during 2002-07 was follows: 1.021, 1.024, 1.030, 1.030, 1.041 and 1.044, respectively [@bib15]. Statistical analysis was performed using the χ^2^ test. A *p*-value \<0.05 was considered statistically significant.

3. Results {#sec3}
==========

The survey included 109 (14%) of 774 colorectal hospitals in Korea. [Table 1](#tbl1){ref-type="table"} shows the status of HIV test in colorectal hospitals. HIV test was taken in 102 hospitals (94%) and 48 hospitals (44%) performed HIV test in-house. The main reason for recommending an HIV test to patients was for operation (54%) followed by for endoscope (11%) and on health checkup (9%). HIV test before endoscopy was deemed necessity in 44 (40%) of responding hospitals. The major reason for not doing an HIV test before endoscopy was that it was not covered by insurance (47%), followed by it was deemed unnecessary (34%).

The status of HIV tests in 48 colorectal hospitals performing HIV tests in-house are shown in [Table 2](#tbl2){ref-type="table"}. Thirty-one (65%) hospitals began to take HIV tests from 2000. Antigen/antibody enzyme-linked immunosorbent assay (ELISA) was performed in 22 hospitals (46%).

[Table 3](#tbl3){ref-type="table"} shows the annual number of HIV tests and HIV seroprevalence in colorectal hospitals from 2002 through 2007. The annual number of HIV test increased from 58,647 (at 21 hospitals) in 2002 to 246,709 (at 58 hospitals) in 2007. HIV seroprevalence was \>3.0 per 10,000 individuals until 2005, decreased to 2.2 per 10,000 individuals in 2006, and increased to 2.8 per 10,000 individuals in 2007.

4. Discussion {#sec4}
=============

We looked at the status of HIV tests and HIV seroprevalence in colorectal hospitals, which treat more patients with benign anal diseases than general hospitals. HIV tests in colorectal hospitals were performed before surgical operations and when HIV infection was suspected. During the analyzed period, HIV seroprevalence of patients in colorectal hospitals was 2.2--3.9 per 10,000 individuals, whereas that in hospitals/clinics was 1.1--1.5 in Korea [@bib15]. HIV seroprevalence in colorectal hospitals was thus 2--3 times higher than that of general hospitals/clinics ([Figure](#fig1){ref-type="fig"}). The number of individuals taking HIV test has increased in colorectal hospitals and general hospitals/clinics. The effect of increased numbers of HIV test takers was contrasting; HIV seroprevalence in general hospitals/clinics has not increased because of a rough balance between the number of HIV-infected individuals and test takers, whereas that in colorectal hospitals has decreased because of higher proportional increases in the latter than the former parameter.

Koreans aged in their 50s are advised to take periodical colonoscopies for early detection of colorectal cancer, which has one of the highest prevalences among malignancies in Korea [@bib16]. As the number of colonoscopy increases, so does the risk of infection by colonoscopy. However, our results showed that the decision to undertake HIV tests prior to colonoscopy was not governed by necessity, but rather by health insurance coverage. Korean health insurance policy deems that only the following cases are covered by health insurance for HIV tests: organ transplant; patients scheduled for surgical operation or transfusion, severely infected patients, patients with pyrexia of unknown origin, dialysis, untypical skin ailment or lymphatic swelling of unknown origin, homosexuals, prostitutes, injection drug users with histories of sexually transmitted disease and possible HIV infection, others suspected for HIV infection, and pregnant women [@bib17]. Most of the cases in colorectal hospitals/clinics were patients scheduled for surgical operation or transfusion and suspected for HIV infection.

In this study, the proportion of HIV test fees not covered by national health insurance decreased since 2002. In 2002, the insurance claim for HIV tests at colorectal hospitals was much higher than that of general hospitals, but each year the claim decreased, finally to the level of general hospitals ([Table 4](#tbl4){ref-type="table"}). This can be interpreted as being that HIV tests were performed for patients eligible for insurance claim in 2002, whereas thereafter the population enlarged to include those who were not eligible for insurance, and so that the HIV seroprevalence in 2006 and 2007 decreased although the number of HIV tests and confirmed HIV-infected patients increased in colorectal hospitals.

HIV tests are necessary to prevent infection during diagnosis and treatment such as transfusion and to prevent transmission by persons who do not know that they are HIV infected. A recent study on the survival rate of HIV-infected persons suggests that if they are identified and receive adequate treatment they can extend their lives by 16--30 years [@bib18]. To prevent HIV infection and to extend the survival time of HIV infected individuals by early detection, US Centers for Disease Control recommends that all Americans aged 13--64 years take HIV tests. Furthermore, high-risk groups should take the tests every year [@bib19]. Korea has also run more active program for early detection since 2008; anonymous tests extended to hospitals.

Moreover, most newly identified infected persons start undergoing immediate treatment due to detection in late disease progression [@bib20]; 700--800 newly identified HIV infected persons are added each year. However, we need to improve the current national surveillance system in Korea. More than 70% of HIV-infected persons are identified by tests in hospitals/clinics. We developed methods to estimate HIV tests and HIV seroprevalence in previous study [@bib15]. Our next study will investigate departmental differences of HIV seroprevalence in hospitals/clinics because we noticed that a high seroprevalence in a branch of colorectal hospitals in this study.

This study has two main limitations. First, we applied the numbers of repeat tests from the previous study on HIV seroprevalence in general hospitals/clinics to estimate the HIV seroprevalence in colorectal hospitals. Second, the low response rate (14%) may have led to selection bias; most responding hospitals were large-sized hospitals.

HIV/AIDS in Korea is mainly infected by sexual contact and is dominated by infected men. This characteristic supports our study results on colorectal hospitals and suggests that the national HIV surveillance system should be fortified for colorectal patients.
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###### 

Status of HIV test in colorectal hospitals in Korea

                                                                          No. cases[a](#tbl1fna){ref-type="table-fn"} (%)
  ----------------------------------------------------------------------- -------------------------------------------------
  Responding hospitals                                                    109 (100)
  Where to perform HIV test                                               
   Independent HIV test in-hospital                                       48 (44.0)
   Refer to clinical laboratory                                           54 (49.5)
   No HIV test                                                            7 (6.5)
  Case of recommendation for HIV test[a](#tbl1fna){ref-type="table-fn"}   
   Operation                                                              59 (54.1)
   Endoscope                                                              12 (11.0)
   Health checkup                                                         10 (9.2)
   Suspected HIV infection                                                60 (55.0)
  Necessity of HIV test before endoscopy                                  
   Yes                                                                    44 (40.4)
   No                                                                     62 (56.9)
   No response                                                            3 (2.8)
  Reason for not performing HIV test before endoscopy                     
   Refusal by a patient                                                   12 (11.0)
   Not covered by insurance                                               51 (46.8)
   Not necessary                                                          37 (33.9)
   No response                                                            9 (8.3)

Multiple responses allowed.

###### 

Initiation and method of HIV tests in 48 colorectal hospitals in Korea

                              No. cases (%)
  --------------------------- ---------------
  Starting year of HIV test   
   Before 1990                7 (14.6)
   1990--1999                 10 (20.8)
   2000--2009                 31 (64.6)
  Testing method              
   ELISA (Ab)                 14 (29.2)
   ELISA (Ag +Ab)             22 (45.8)
   Rapid test                 11 (22.9)
   No response                1 (2.1)

###### 

Number of HIV tests and HIV seroprevalence in colorectal hospitals, 2002--2007

                         2002     2003      2004      2005      2006      2007
  ---------------------- -------- --------- --------- --------- --------- ---------
  No. hospitals          21       31        35        45        52        58
  No. HIV test           58,647   147,395   164,022   200,013   223,311   246,709
  No. detection of HIV   21       51        50        75        47        65
  HIV seroprevalence     3.7      3.5       3.1       3.9       2.2       2.8

HIV seroprevalence is the number of the HIV-infected per 10,000 individuals.

###### 

Annual insurance claim proportion for HIV testing in colorectal hospitals in Korea

                                                                     2002   2003   2004   2005   2006   2007
  ------------------------------------------------------------------ ------ ------ ------ ------ ------ ------
  Insurance claim proportion (%)[a](#tbl4fna){ref-type="table-fn"}   69.7   34.6   34.0   35.4   33.9   25.7

Insurance claim proportion, (no. insurance claims for HIV test/no. of HIV tests) × 100.
